Kaiser Permanente Ventures and Samsung Next invested in the digital mental health treatment developer through a series B round that will fund product development and commercialisation.

US-based mental health treatment developer Big Health has secured $39m in a series B round featuring Kaiser Permanente Ventures and Samsung Next, subsidiaries of healthcare provider Kaiser Permanente Ventures and electronics producer Samsung.

Healthcare investment firm Gilde Healthcare and venture capital firm Morningside Ventures co-led the round, which included VC firm Octopus Ventures.

Janke Dittmer, a general partner at Gilde, is joining Big Health’s board of directors along with Morningside partner Isaac Cheng. Liz Rockett, director at Kaiser Permanente Ventures,…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Robert Lavine

Robert Lavine is special features editor for Global Venturing.
Email LinkedIn